Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

High levels of 25-hydroxyvitamin D (top quintile) were associated with a reduced multiple sclerosis risk (odds ratio 0.68, 95% confidence interval 0.50 to 0.93).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In this nested case: control study we accessed five Swedish microbiological biobanks associated with university hospitals in Umeå, Örebro, Göteborg, Skåne and Linköping and one biobank from the Public Health Agency of Sweden (PHAS), to obtain serum or plasma from a total of 670 individuals who later developed RRMS and 670 controls matched for biobank and sex, and with decreasing priority for date of sampling and age.

Source: Methods.

All samples from MS patients were collected 8 years prior to symptom onset (in median) and all participants were below 40 years of age at the time of sampling.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

High serum concentration of vitamin D may protect against multiple sclerosis

Case-control study · Multiple Sclerosis Journal: Experimental, Translational and Clinical · 2019

Original publication title

High serum concentration of vitamin D may protect against multiple sclerosis

Martin Biström; Lucia Alonso-Magdalena; Oluf Andersen; Daniel Jons; Martin Gunnarsson; Magnus Vrethem; Johan Hultdin; Peter Sundström

© The Author(s) 2019

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These findings further support a role for vitamin D in MS aetiology.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Investigate the 25-hydroxyvitamin D association with multiple sclerosis and test if this association is age dependent.

Source: Objective

Abstract: What methods does the paper describe?

Prospectively drawn blood samples from individuals later developing relapsing: remitting multiple sclerosis and controls matched for biobank, sex, age and date of sampling, were analysed with liquid chromatography tandem mass spectrometry.

Source: Methods

Abstract: Results

High levels of 25-hydroxyvitamin D (top quintile) were associated with a reduced multiple sclerosis risk (odds ratio 0.68, 95% confidence interval 0.50 to 0.93).

Source: Results

Abstract: Conclusion

These findings further support a role for vitamin D in MS aetiology.

Source: Conclusion
Authors’ abstract

Background

High 25-hydroxyvitamin D concentrations have been associated with a reduced risk of multiple sclerosis, with indications of a stronger effect among young individuals.

Objective

Investigate the 25-hydroxyvitamin D association with multiple sclerosis and test if this association is age dependent.

Methods

Prospectively drawn blood samples from individuals later developing relapsing: remitting multiple sclerosis and controls matched for biobank, sex, age and date of sampling, were analysed with liquid chromatography tandem mass spectrometry.

Results

High levels of 25-hydroxyvitamin D (top quintile) were associated with a reduced multiple sclerosis risk (odds ratio 0.68, 95% confidence interval 0.50 to 0.93).

Conclusion

These findings further support a role for vitamin D in MS aetiology.

Publication and source details

Original title: High serum concentration of vitamin D may protect against multiple sclerosis

Martin Biström; Lucia Alonso-Magdalena; Oluf Andersen; Daniel Jons; Martin Gunnarsson; Magnus Vrethem; Johan Hultdin; Peter Sundström

Multiple Sclerosis Journal: Experimental, Translational and Clinical · 2019

Umeå University, Department of Pharmacology and Clinical Neuroscience, Section of Neurology, Umeå, Sweden.martin.bistrom@umu.se© The Author(s) 20192019SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenseshttps://creativecommons.org/licenses/by/4.0/Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Vetenskapsrådethttps://doi.org/10.13039/5011000043592015-02419Regional agreement between Umeå University and Västerbotten County Council (ALF)RV-751881

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T18:34:56.033498+00:00

DOI: 10.1177/2055217319892291 · PMC6900627